QNCX logo
QNCX NASDAQ US

Quince Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO May 2019
$0.10
▼ $0.00 (-2.94%)
Vol 8.7M
3
Quality Score
fail
Mkt Cap
$186.5M
ROE
-370.5%
D/E
1654.39
Beta
1.21
52W
$1–$5

Wall Street Consensus

9 analysts · Apr 2026
0
Strong Buy
0
Buy
5
Hold
2
Sell
2
Strong Sell
0.0%
Buy Rating

Price Chart

Similar Stocks

BRTX
BioRestorative Therapies Inc
$10.4M
ERNA
Ernexa Therapeutics Inc
$9.4M
ENSC
Ensysce Biosciences Inc
$3.3M
MBIO
Mustang Bio Inc
$7.2M
SBFM
Sunshine Biopharma Inc
$6.0M
AKTX
Akari Therapeutics PLC
$9.4M
FBLG
Fibrobiologics Inc
$15.0M

Earnings

Beat rate: 25.0%
Next Report May 11, 2026
EPS Estimate: $-0.23
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.23 — —
Sep 2025 $-0.22 $-0.25 $-0.03
Jun 2025 $-0.26 $-0.23 +$0.03
Mar 2025 $-0.23 $-0.34 $-0.11

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -186.1% -186.1% -186.1% -186.1% -186.1% -370.5%
P/E (TTM) — — — — — —
Net Margin — — — — — —
Gross Margin — — — — — —
D/E Ratio 144.76 144.76 144.76 144.76 144.76 1654.39
Current Ratio 5.00 5.00 5.00 5.00 5.00 1.12

Key Ratios

ROA (TTM)
-50.8%
P/B
2.7
EPS (TTM)
$-1.22
CF/Share
$-0.78
52W High
$4.55
52W Low
$0.72
$0.72 52-Week Range $4.55

How does QNCX compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

QNCX AAPG ABEO ABOS ABP

QNCX valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼ 0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
2.7
▲ 11% above peers (2.5)
vs Peers
vs Industry
Fair value
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

QNCX profitability vs Biotechnology peers

ROE
-370.5%
▼ 450% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼ 0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-50.8%
▼ 9% below peers (-46.7%)
vs Peers
vs Industry
In line

QNCX financial health vs Biotechnology peers

D/E ratio
1654.4
▼ 0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
1.1
▼ 75% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.2
▲ 24% above peers (1.0)
vs Peers
vs Industry
More volatile

QNCX fundamentals radar

QNCX Peer median Industry

QNCX profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

QNCX vs peers: key metrics

Latest News

No related news yet